Reported yesterday, the drug telcagepant is offering new hope to some migraine sufferers. It is another drug that shows success in treating the pain phase of migraine. It has typically fewer side-effects that existing drugs.
It may offer hope to patients who cannot take, or don’t benefit from, triptans. These include those with heart disease, high blood pressure and some types of migraine.
A randomized study of 1,380 people in 81 hospitals in the US and Europe showed telcagepant was as effective as zolmitriptan, but with fewer side-effects. But further research is necessary before this can be used generally as a migraine treatment.
Sources
http://www.telegraph.co.uk/health/healthnews/3514398/New-era-in-migraine-medication.html
http://en.wikipedia.org/wiki/Calcitonin_gene-related_peptide
